UNSPSC 51272401: Desflurane

This classification denotes an anesthetic agent with the molecular formula C3H2F6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CRS35BZ94Q, chemically known as 1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane but generally known as desflurane, which bears US NIH Compound Identifier 42113. European Medicines Agency schedules Desflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06993MIG.

UNSPSC 51272401 Desflurane is a Commodity code that covers pharmaceutical products sourced through state and local procurement channels, though recent state and local opportunities tagged with this code reveal a broader purchasing focus on naloxone, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products rather than desflurane specifically. State and local governments procuring under this code include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. The work involves competitive procurement of pharmaceutical inventory to support community health initiatives, public health programs, and government employee benefit plans, with vendors required to meet cGMP certification, DSCSA compliance, FDA approval, insurance coverage requirements, and federal employment verification standards.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, targeting direct contracting between state agencies and pharmaceutical manufacturers outside traditional pharmacy benefit managers. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities across multiple states, with proposals due March 26, 2026 and performance requirements including authorized wholesaler relationships and compliance with a 3 percent administrative fee structure.